Medtronic: EPS up 7% in Q3
(CercleFinance.com) - Medtronic has reported non-GAAP net income of $1.
79bn for Q3, representing EPS that is up 7% to $1.39, on revenues of $8.29bn, up 2.5% (+4.1% organic). NB: pmt -2.6%.
We are starting to see the fruits of our long-term investments in breakthrough innovations, such as electroporation, to drive growth in some of medtech's most attractive markets, management said.
For FY 2024-25, the medical equipment supplier confirms that it is targeting non-GAAP EPS of $5.44 to $5.50, as well as annual organic revenue growth of between 4.75% and 5%.
Copyright (c) 2025 CercleFinance.com. All rights reserved.